Literature DB >> 10829045

Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer.

B Meiser1, P Butow, M Friedlander, V Schnieden, M Gattas, J Kirk, G Suthers, E Haan, K Tucker.   

Abstract

PURPOSE: To assess intention to undergo prophylactic bilateral mastectomy and psychologic determinants in unaffected women at increased risk of developing hereditary breast cancer. PATIENTS AND METHODS: Three hundred thirty-three women who were awaiting their initial appointments for risk assessment, advice about surveillance, and prophylactic options at one of 14 familial cancer clinics participated in a cross-sectional, questionnaire-based survey.
RESULTS: Nineteen percent of women would consider and 47% would not consider a prophylactic mastectomy, should genetic testing identify a mutation in a breast cancer-predisposing gene, whereas 34% were unsure and 1% had already undergone a prophylactic mastectomy. In a bivariate analysis, women at a moderately increased risk of developing breast cancer had the highest proportion of subjects reporting that they would consider a prophylactic mastectomy (25%), compared with women at high risk (16%) (chi(2) = 7.79; P =.051). In multivariate analyses, consideration of prophylactic mastectomy strongly correlated with high levels of breast cancer anxiety (odds ratio [OR] = 17.4; 95% confidence interval [CI], 4.35 to 69.71; P =. 0001) and overestimation of one's breast cancer risk (OR = 3.01; 95% CI, 1.43 to 6.32; P =.0036), whereas there was no association with objective breast cancer risk (P =.60).
CONCLUSION: A significant proportion of women at increased risk of developing hereditary breast cancer would consider prophylactic mastectomy. Although prophylactic mastectomy may be appropriate in women at high risk of developing breast cancer, it is perhaps less so in those who have a moderately increased risk. Such moderate-risk women are likely to benefit from interventions aimed at reducing breast cancer anxiety and correcting exaggerated breast cancer risk perceptions.

Entities:  

Mesh:

Year:  2000        PMID: 10829045     DOI: 10.1200/JCO.2000.18.11.2250

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  28 in total

1.  Is it time to offer BRCA1 and BRCA2 testing to all Jewish women?

Authors:  K A Metcalfe; A Eisen; J Lerner-Ellis; S A Narod
Journal:  Curr Oncol       Date:  2015-08       Impact factor: 3.677

2.  Short- and long-term impact of receiving genetic mutation results in women at increased risk for hereditary breast cancer.

Authors:  Jacqueline Lim; Mariette Macluran; Melanie Price; Barbara Bennett; Phyllis Butow
Journal:  J Genet Couns       Date:  2004-04       Impact factor: 2.537

3.  BRCA1/2 test results impact risk management attitudes, intentions, and uptake.

Authors:  Suzanne C O'Neill; Heiddis B Valdimarsdottir; Tiffani A Demarco; Beth N Peshkin; Kristi D Graves; Karen Brown; Karen E Hurley; Claudine Isaacs; Sharon Hecker; Marc D Schwartz
Journal:  Breast Cancer Res Treat       Date:  2010-04-10       Impact factor: 4.872

4.  Women's interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aid.

Authors:  Angela Fagerlin; Amanda J Dillard; Dylan M Smith; Brian J Zikmund-Fisher; Rosemarie Pitsch; Jennifer B McClure; Sarah Greene; Sharon Hensley Alford; Vijayan Nair; Daniel F Hayes; Cheryl Wiese; Peter A Ubel
Journal:  Breast Cancer Res Treat       Date:  2011-03-26       Impact factor: 4.872

5.  Predictors of risk-reducing surgery intentions following genetic counseling for hereditary breast and ovarian cancer.

Authors:  Mary Kathleen Ladd; Beth N Peshkin; Leigha Senter; Shari Baldinger; Claudine Isaacs; Hannah Segal; Samantha Philip; Chloe Phillips; Kate Shane; Aimee Martin; Veronique Weinstein; Robert Pilarski; Joanne Jeter; Kevin Sweet; Bonnie Hatten; Elisabeth J Wurtmann; Shanda Phippen; Della Bro; Marc D Schwartz
Journal:  Transl Behav Med       Date:  2020-05-20       Impact factor: 3.046

6.  Reducing Psychological Distress in a Genetic Counseling Consultation for Breast Cancer.

Authors:  Vlatka Duric; Phyllis Butow; Louise Sharpe; Elizabeth Lobb; Bettina Meiser; Alexandra Barratt; Katherine Tucker
Journal:  J Genet Couns       Date:  2003-06       Impact factor: 2.537

7.  Female BRCA mutation carriers with a preference for prophylactic mastectomy are more likely to participate an educational-support group and to proceed with the preferred intervention within 2 years.

Authors:  Karin M Landsbergen; Judith B Prins; Yvonne J L Kamm; Han G Brunner; Nicoline Hoogerbrugge
Journal:  Fam Cancer       Date:  2010-06       Impact factor: 2.375

8.  Predictors of cancer worry in unaffected women from high risk breast cancer families: risk perception is not the primary issue.

Authors:  Melanie Anne Price; Phyllis Noami Butow; Sing Kai Lo; Judy Wilson
Journal:  J Genet Couns       Date:  2007-09-09       Impact factor: 2.537

9.  Psychosocial factors and uptake of risk-reducing salpingo-oophorectomy in women at high risk for ovarian cancer.

Authors:  Bettina Meiser; Melanie A Price; Phyllis N Butow; Janan Karatas; Judy Wilson; Louise Heiniger; Brandi Baylock; Margaret Charles; Sue-Anne McLachlan; Kelly-Anne Phillips
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

10.  Risk perception after genetic counseling in patients with increased risk of cancer.

Authors:  Johanna Rantala; Ulla Platten; Gunilla Lindgren; Bo Nilsson; Brita Arver; Annika Lindblom; Yvonne Brandberg
Journal:  Hered Cancer Clin Pract       Date:  2009-08-23       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.